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Abstract
Canonical Wnt/b-catenin signaling regulates stem/progenitor cells and, when perturbed, induces many human cancers. A
significant proportion of human breast cancer is associated with loss of secreted Wnt antagonists and mice expressing MMTV-
Wnt1 and MMTV-DN89b-catenin develop mammary adenocarcinomas. Many studies have assumed these mouse models of
breast cancer to be equivalent. Here we show that MMTV-Wnt1 and MMTV-DN89b-catenin transgenes induce tumors with
different phenotypes. Using axin2/conductin reporter genes we show that MMTV-Wnt1 and MMTV-DN89b-catenin activate
canonical Wnt signaling within distinct cell-types. DN89b-catenin activated signaling within a luminal subpopulation scattered
along ducts that exhibited a K18
+ER
2PR
2CD24
highCD49f
low profile and progenitor properties. In contrast, MMTV-Wnt1 induced
canonical signaling in K14
+ basal cells withCD24/CD49fprofilescharacteristic of two distinct stem/progenitorcell-types.MMTV-
Wnt1 produced additional profound effects on multiple cell-types that correlated with focal activation of the Hedgehog
pathway. Wedocument thatlargemelanocytic neviare a hithertounreported hallmark ofearlyhyperplastic Wnt1glands. These
nevi formed along the primary mammary ducts and were associated with Hedgehog pathway activity within a subset of
melanocytes and surrounding stroma. Hh pathway activity also occurred within tumor-associated stromal and K14
+/p63
+
subpopulations in a manner correlated with Wnt1 tumor onset. These data show MMTV-Wnt1 and MMTV-DN89b-catenin
induce canonical signaling in distinct progenitors and that Hedgehog pathway activation is linked to melanocytic nevi and
mammary tumor onset arising from excess Wnt1 ligand. They further suggest that Hedgehog pathway activation maybe a
critical component and useful indicator of breast tumors arising from unopposed Wnt1 ligand.
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Introduction
Wnts are a family of secreted proteins that regulate tissue
patterning and homeostasis. The canonical Wnt pathway operates
by inhibiting proteolysis of cytoplasmic b-catenin, which enters the
nucleus and regulates transcription through Lef/Tcf DNA binding
partners. It is well documented that canonical Wnt/b-catenin
signaling is required for the viability of particular stem cells, and
forced activation of this pathway can expand stem/progenitors,
alter cell fate and induce tumorigenesis [1–3].
Multiple lines of evidence demonstrate roles for Wnt/b-catenin
signaling in mammary development and breast cancer [4,5].
Multiple Wnts are expressed throughout mammary development.
Mice expressing Wnt inhibitors, or deficient in Lef-1, show defective
embryonic mammary development, and loss of the Wnt coreceptor,
LRP5/6, impairs postnatal development [6–9]. Both loss- and gain-
of-function studies have established roles for Wnt4 and Wnt5a in
ductal side branching and for b-catenin signaling in alveologenesis
and survival [10–15]. Although b-catenin mutations have not been
found in breast cancer, pathway activation due to loss of the
extracellular Wnt antagonist, sFRP1, is a frequent event [4,5,16]. In
mice, expression of Wnt1 and stabilized b-catenin (DN89b-catenin)
under the control of the mouse mammary tumor virus LTR
(MMTV) induces precocious mammary development and adeno-
carcinoma formation [13,17,18]. Tumors induced by both trans-
genes are enriched in side-population content and cells expressing
primitive cell markers that exhibit greater colony-forming capabil-
ities. Collectively, these studies have lead to the hypothesis that
canonical Wnt/b-cateninsignalingpredisposesmicetobreastcancer
by amplifying stem/progenitor populations [4,18–22].
Recent studies have shown that only a minor subpopulation of
human breast tumor cells can propagate tumors [23]. Such tumor-
initiating cells (TICs) share with normal stem cells the ability to
self-renew and to generate differentiated progeny. Although
commonly referred to as cancer stem cells (CSCs), it is unclear
whether TICs derive from stem cells and/or from less potent
progeny that acquire stem cell properties during transformation.
Moreover, the contribution of distinct cancer stem cells to breast
cancer heterogeneity remains obscure. Candidate mammary stem
and progenitor populations have been identified by ultrastructural
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efflux Hoechst 33342 dyes, which upon cell sorting generates a
side-population [24–26]. Recent sorting studies of murine
mammary cells have identified a subpopulation, with a lineage-
depleted (Lin
2)/CD24
low/CD29/49f
high/ Sca-1
2/keratin (K)14
+
profile, that are enriched in ‘‘mammary repopulating units’’
(MRUs), which have a parent-progeny relationship with a second
Lin
2/CD24
high/CD29/49f
low subpopulation of alveolar-limited
progenitors expressing a predominantly luminal K18
+ profile
[21,27]. Other studies have described luminal progenitor popu-
lations with CD24
high/CD133
2/K18
+ and Lin
2/CD24
+/
CD29
low/CD61
+ K14
+ profiles [28,29]. A study on human breast
strongly supports the concept of a multipotent stem cell located
within a ductal luminal niche that expresses multiple keratins [30].
Recently the connection between the physiological role of Wnt
signaling in stem cells and its capacity to induce cancer when
upregulated has been exploited to identify intestinal stem cells by
virtue of their expression of a Wnt-responsive gene, Lgr5, that was
initially found to be upregulated in colonic tumors [31]. This study
suggests that identifying cell-types that respond to Wnt signaling
may be an alternative route to identify and illuminate the
relationship between mammary stem/progenitor cells and cancer
stem cells. With this aim in mind, we employed Wnt-responsive
conductin/Axin2 reporter genes to identify and isolate cells
showing transcriptional response to expression of MMTV-
DN89b-catenin and MMTV-Wnt1 transgenes. Our results show
that these transgenes lead to activation of the canonical Wnt
pathway in distinct cell-types displaying progenitor and stem cell
characteristics and induce tumors with different phenotypes. A
further source of disparity between these tumors arises from the
unique ability of Wnt1 to influence multiple cells types within the
gland. We show that these profound effects correlate with focal
induction of Hedgehog (Hh) pathway activity within subpopula-
tions of stromal and basal (K14
+/p63
+) cells found exclusively
within the Wnt-1 tumor microenvironment, as well as, in and
around melanocytic hyperplastic nevi, which form a hallmark of
all MMTV-Wnt1 mammary glands. These data show that Hh
pathway activation is linked to Wnt-1-induced mammary tumor
onset and nevi formation and suggest that Hedgehog pathway
activation maybe a critical component and useful marker of breast
tumors arising from unopposed Wnt1 ligand.
Results
MMTV-Wnt1 and MMTV-DN89b-catenin show
phenotypic disparity
MMTV-Wnt1 and MMTV-DN89b-catenin induce precocious
mammary development and adenocarcinoma formation [13,17].
However, the two types of transgenic lines differ in their lactational
competence [13,17]. This functional disparity led us to examine the
respective mammary phenotypes for morphological differences that
may yield insight into the corresponding pathobiological mecha-
nisms. In glands expressing MMTV-DN89b-catenin acini budded
directly from ductal borders (Fig. 1A), and were associated with
spindle-shaped K14
+ basal cells (Fig. 1B), which resembled flattened
myoepithelial cells of normal alveoli. However, the ducts, visualized
by a ductal luminal cell marker, latent transforming growth factor-b-
binding protein (LTBP)1-lacZ (Fig. 1C, E), were similar to those of
controls (Fig. 1D). In contrast, MMTV-Wnt1 expression induced
pronounced ductal changes, including hyperbranching (Fig. 1F).
These hyperplasias were encased in a coherent thick K14
+ cell layer
(Fig. 1G), which resembled the myoepithelial layers ensheathing
normal ducts. Ductal contortion (Fig. 1H), cyst formation (Fig. 1I),
and lumenal occlusions (Fig. 1J) were prominent. The cellular
composition and architecture of the tumors induced by the
transgenes also showed subtle but important differences. Tumors
from MMTV-DN89b-catenin mice contained many more K18
+
than K14
+ cells and were hormone receptor-negative (Fig. 2A–C).
These frequently retained well-differentiated acinar polarization,
with luminal cells expressing apical mucin (MUC)1 (Fig. 2D) and
showing basal deposition of laminin V (Fig. 2E). Stromal cells,
detected by vimentin antibodies, were sparse (Fig. 2F). Tumors from
MMTV-Wnt1 mice displayed bi-layered papillary arrays of cells,
showed an equal ratio of K14
+/K18
+ cells and expressed hormone
receptors (Fig. 2G–I). They showed loss of polarized organization;
indicated byreduced MUC1expression (Fig. 2J),frequentlamininV
accumulationinpatches(Fig.2K),andstromalhypertrophy(Fig.2L).
In conclusion, expression of MMTV-DN89b-catenin induced
expansion of hormone-receptor-negative, K18
+ cells, which main-
tained alveolar features and were lactationally competent, whereas
MMTV-Wnt1 expression significantly expanded K14
+ cells in
addition to both hormone-receptor-positive and -negative K18
+ cells
and lead to perturbed ductal formation and lactational failure.
MMTV-Wnt1 and MMTV-DN89b-catenin activate the
canonical signaling pathway within different cell-types
Based on the disparate phenotypes described above, we hypoth-
esized that DN89b-catenin and Wnt1 transform different progenitors.
The MMTV-LTR is expressed within mammary luminal epithelium.
Therefore b-catenin’s transcriptional effects are restricted to cells
within this layer, whereas Wnt1, a secreted factor, can act in an
autocrine and/or paracrine fashion in any cells that expresses a Wnt1
receptor. To determine which cell-types respond to the expression of
these transgenes via activation of the canonical pathway, we crossed
MMTV-DN89b-catenin and MMTV-Wnt1 mice to Axin2-d2EGFP
transgenic and Conductin
+/lz heterozygous lacZ knock-in reporter lines.
The Axin2/Conductin gene is expressed constitutively in response to
canonical Wnt/b-catenin signaling and its product negatively
regulates the pathway [32,33]. Despite uniform expression of
MMTV-DN89b-catenin within the luminal epithelium [13], tran-
scriptional response, detected by Conductin-lacZ reporter expression,
was restricted to a subpopulation of luminal cells scattered along
secondary and tertiary ducts (Fig. 3A). In early hyperplasia,
approximately one luminal cell per alveolus expressed Conductin-lacZ
(Fig. 3B) and these cells became more prominent as the hyperplasia
increased but the main ducts remained devoid of b-catenin signaling
(Fig. 3C). In contrast, mammary glands from MMTV-Wnt1 mice
showed a strikinglyuniformConductin-lacZexpression pattern along the
entire mammary ductal system (Fig. 3D and F) and the reporter was
found exclusively within basal cells (Fig. 3E). These distinct cellular
patterns of transcriptional response were maintained in tumors
(Fig. 4A–F). In tumors from MMTV-DN89b-catenin mice, Conductin-
lacZwas expressed within cells expressing the luminal marker K18 and
absent from K14
+ cells (Fig. 4A–C). Wnt1 tumors showed the
converse expression pattern; Conductin-lacZ expressing cells were
restricted to a single K14
+/K18
2 layer of the bilayered papillary
tumors (Fig. 4D–F). In conclusion, these data show that a subset of
K18
+ cells respond to DN89b-catenin. K18
+ luminal epithelial cells
from MMTV-Wnt1 mice fail to respond, suggesting they lack a Wnt1
receptor, or that autocrine canonical pathway activity is suppressed by
non-canonical antagonism within this cell-type. In contrast, K14
+cells
show a robust paracrine canonical response to Wnt1.
MMTV-DN89b-catenin and MMTV-Wnt1 amplify cells
with distinct CD24/49f stem/progenitor profiles
To further compare the cell-type composition of tumors, we
isolated mammary epithelial cells (MECs) from tumors of MMTV-
Wnt/Hh in Mammary Tumors
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expression of CD24 and CD49f. These markers separate MECs
from wt mice into two roughly equal populations by flow
cytometry: CD24
highCD49f
low and CD24
lowCD49f
high (Fig. 5G).
The most rightward and upward shifted cells within each of these
populations have been reported to be enriched in colony-forming
cell (CFC) comprising alveolar progenitors and multipotent
mammary repopulating units (MRUs), respectively [27]. DN89b-
catenin tumors were enriched for CD24
highCD49f
low MECs
(Fig. 5A) (62% compared to 37% CD24
lowCD49f
high). In contrast,
Wnt1 tumors were enriched for CD24
lowCD49f
high MECs
(Fig. 5D) (65%, compared to 35% CD24
highCD49f
low). To
characterize cells undergoing an active transcriptional response
to expression of these transgenes, we crossed MMTV-Wnt1 and
MMTV-DN89b-catenin lines to the Axin2-d2EGFP reporter
mouse, isolated tumor MECs from the bitransgenic progeny and
analyzed them for enhanced green fluorescent protein (EGFP) and
CD24/CD49f expression by flow cytometry. In contrast to the
Figure 1. Phenotypic differences between MMTV-DN89b-catenin and MMTV-Wnt1 hyperplasias. Mammary glands from 12 week-old
virgin MMTV-DN89b-catenin (MMTV-DN89b-cat) (A–E) and MMTV-Wnt1 (F–J) mice. Mammary whole mounts stained with carmine (A, F) or X-Gal (C, D,
H, I). Sections stained immunohistochemically with anti-K14 antibodies to detect the basal cells (B, G) or with X-Gal to detect luminal LTBP1-lacZ
expression and nuclear fast red (E, J). Note mammary glands from MMTV-DN89b-catenin mice show alveolar hyperplasia (A, B) but their ductal system
(C, E) is comparable to controls (D). Mammary glands from MMTV-Wnt1 mice show hyperbranching (F), K14
+ cell ensheathment (G), ductal
constriction (arrows H, J) and large ductal cysts (arrows F, I).
doi:10.1371/journal.pone.0004537.g001
Wnt/Hh in Mammary Tumors
PLoS ONE | www.plosone.org 3 February 2009 | Volume 4 | Issue 2 | e4537Figure 2. MMTV-DN89b-catenin and MMTV-Wnt1 tumors have distinct cellular composition. Tumor sections from MMTV-DN89b-catenin
(MMTV-DN89b-cat) (A–F) and MMTV-Wnt1 (G–L) stained with antibodies as indicated against K14, K18, estrogen receptor (ER), MUC1, laminin, and
vimentin. Note distorted laminin deposition (Arrows in K) and stromal hyperplasia (L).
doi:10.1371/journal.pone.0004537.g002
Wnt/Hh in Mammary Tumors
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2 cells from MMTV-DN89b-catenin
mice between the two major CD24/CD49f cell populations
(Fig. 5B), cells expressing high levels of EGFP
hi (top 15%) (Fig. 5C)
fell exclusively within the CD24
highCD49f
low subpopulation and
showed an upward rightward shift in mean fluorescence intensity,
suggestive of CFCs. To test the functional significance of these
observations, we compared the ability of EGFP
+, EGFP
2 and total
MECs from MMTV-DN89b-catenin mice to form colonies at
limiting dilution. EGFP
+ cells showed 3-5-fold greater colony
forming efficiency compared to total sorted cells, and a
corresponding depletion of colony-forming efficiency was found
within the EGFP
2 cell population (Fig. 5H). Immunofluorescence
analysis showed that EGFP
+ cells produced colonies composed of
mixed progeny, with some cells expressing K8 and others K14
(Fig. 5I). We conclude that DN89b-catenin signaling cells within
tumors show marker expression profiles that mirror those of CFC
alveolar progenitors from normal gland and are bipotent, giving
rise to luminal and basal cell types in vitro. In contrast, EGFP
2
(Fig 5E) and EGFP
hi (Fig. 5F) cells from MMTV-Wnt1 mice were
distributed in both CD24/CD49f subpopulations. However, the
EGFP
hi (Fig. 5F) cells were skewed to the right side of the
CD24
highCD49f
low population and those within the
CD24
lowCD49f
high subpopulation showed an upward rightward
shift. These shifts are consistent with the profiles of CD61
+/K14
+
progenitors and of MRUs that have been shown in previous
reports to have CSC capabilities [22,27,28,34].
MMTV-Wnt1 expression induces Hh pathway activation
within the tumor
Wnt and Hh pathways are frequently coupled in the cross-talk
between stem cells and their stromal niche and an essential linkage
between these pathways has been documented recently in basal
cell skin cancer [35]. To determine if the Hh pathway was
activated in hyperplasia and tumors of MMTV-Wnt1 and
MMTV-DN89b-catenin mice, we crossed these lines to Gli1
+/lz
reporter mice. Hh signals are transduced by members of the Gli
protein family, (Gli1-3). Gli1 is both a transcriptional target gene
and positive amplifier of the pathway. Its expression is strictly
dependent upon Hh signaling and thus provides a reliable reporter
of Hh pathway activation [36]. Hh pathway activity is repressed
within the mammary tree of non-transgenic Gli1
+/lz control glands
and Gli1-lacZ reporter expression was restricted to lymphatics
(Fig. 6A) [37]. Similarly, hyperplasia and tumors from MMTV-
DN89b-catenin;Gli1
+/lz mice showed no evidence of Gli1-lacZ
expression within the epithelial and stromal compartments
(Fig. 6B). In contrast, tumors derived from MMTV-Wnt1;Gli1
+/lz
mice showed robust Gli1-lacZ expression within stromal cells and a
minor subset of basal cell-types, some of which expressed p63
(Fig. 6C, D). Importantly, this reporter expression was restricted to
the tumor bed and not observed in hyperplasia (Fig. 6E). These data
demonstrate that Wnt1 expression leads to aberrant Hh pathway
activation within the Wnt1 tumor microenvironment.
MMTV-Wnt1 expression results in dramatic accumulation
and differentiation of melanocytes along the lactiferous
sinus and primary ducts
Another striking linkage between Hh pathway activation and
MMTV-Wnt1 expression was found in melanocytic hyperplasia
under the nipple region (Fig. 6E box). A hallmark of mammary
glands from pigmented MMTV-Wnt1 mice was accumulation of
melanin around the trunk and primary mammary branches
(Fig. 7A, E). Large black aggregates emanating from the nipple
Figure 3. Conductin-lacZ is expressed in K18
+ subpopulations in MMTV-DN89b-catenin and K14
+ subpopulations in MMTV-Wnt1
hyperplasia. Canonical signaling is activated in disparate cell-types. Sections of hyperplastic glands from (A–C) Conductin
+/lz/MMTV-DN89b-catenin
mice, and (D–F) Conductin
+/lz/MMTV-Wnt1 mice stained with X-gal to detect Conductin-lacZ expression (blue), a reporter of canonical Wnt signaling,
and stained with antibodies against K14 and K18 (brown) as indicated. Note the stromal hypertrophy surrounding Wnt1 hyperplastic ducts (E).
doi:10.1371/journal.pone.0004537.g003
Wnt/Hh in Mammary Tumors
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pad that could be observed by eye (n=29). These were absent
from mammary glands of pigmented wt (n=17) and MMTV-
DN89b-catenin (n=5) mice and from all albino mice regardless of
genotype (n=34 Wnt; n=10 DN89b-catenin; n=13 wild-type).
Mammary whole-mounts (Fig. 7A) and sections (Fig. 7B–C) from
pigmented MMTV-Wnt1 mice revealed melanin deposition
within the basal layer, stromal cells and occasionally within the
secretions of the primary lactiferous ducts. However, immunohis-
tochemical analysis with antibodies against the S100b melanocyte
marker revealed large numbers of dendritic melanocytes in albino
as well as pigmented Wnt1 mice (Fig. 7C, G). We conclude that
Wnt-1 expression leads to migration, accumulation and differen-
tiation of melanocytes along the primary mammary ducts and that
these cells are not present in MMTVDN89b-catenin and wt mice.
To investigate whether Wnt1 induces these effects on
melanocytes through canonical signaling and/or involves Hh
pathway activation, we examined whole mounts of bitransgenic
MMTV-Wnt1;Conductin
+/lz and MMTV-Wnt1;Gli1
+/lz mice for
reporter expression. Conductin-Gal was restricted to basal cells
and absent from the underlying stroma where melanocytes reside
(Fig. 7F). In contrast, prominent Gli1-lacZ reporter expression was
observed exclusively around the primary ducts of all MMTV-
Wnt1;Gli1
+/lz mice (n=8) (Fig. 7D, E), colocalizing with the
melanotic aggregates of pigmented MMTV-Wnt1;Gli1
+/lz mice
(n=4) (Fig. 7E) and within a subset melanocytes identified by
S100b staining and many neighboring fibroblasts in albino
MMTV-Wnt1;Gli1
+/lz mice (n=4) (Fig. 7D, G). Gli1-lacZ
expression was absent from corresponding regions of MMTV-
DN89b-catenin;Gli1
+/lz (n=4) and control Gli1
+/lz (n=2) glands.
We conclude that MMTV-Wnt1 expression induces aberrant
melanocyte accumulation and differentiation within the fatpad
and this event does not involve canonical pathways but correlates
with robust Hh pathway activity within the stroma and a minor
melanocyte subpopulation.
Discussion
The key findings of this study are that MMTV-DN89b-catenin
and MMTV-Wnt1 induce distinct tumors, activate canonical
signaling in disparate cell-types, and MMTV-Wnt1 alone results in
focal Hh pathway activity within the mammary tumor microen-
vironment and in and around melanocytic hyperplasia.
MMTV-DN89b-catenin and MMTV-Wnt1 induce canonical
signaling in distinct cell-types
Previous studies have shown that MMTV-DN89b-catenin and
MMTV-Wnt1 tumors express primitive cell markers and are
enriched in cell populations with stem/progenitor features [19–
21,34]. Our work extends these findings by identifying the cell-
types that undergo a canonical response to transgene expression.
Despite uniform MMTV-DN89b-catenin expression within the
luminal epithelium [13], our results show that a specific subset of
luminal cells express the transcriptional reporter, Conductin-lacZ.
Figure 4. Conductin-lacZ is expressed in K18
+ subpopulations in MMTV-DN89b-catenin and K14
+ subpopulations in MMTV-Wnt1
tumors. Sections of tumors from (A–C) Conductin
+/lacZ/MMTV-DN89b-catenin, and (D–F) Conductin
+/lacZ/MMTV-Wnt1 mice stained with X-gal to
detect Conductin-lacZ expression (blue), a reporter of canonical Wnt signaling, and stained immunohistochemically with antibodies against K14 and
K18 (brown) as indicated.
doi:10.1371/journal.pone.0004537.g004
Wnt/Hh in Mammary Tumors
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negative [38], K18
+CD24
highCD49f
low profile, and generate
colonies containing both K8
+ and K14
+ cells. Thus, they exhibit
the expected location, molecular profile and functional bipotency
ascribed to alveolar progenitor populations from normal mam-
mary glands [21,27]. These features, in conjunction with the
overwhelmingly alveolar-like phenotype of MMTV-DN89b-cate-
nin hyperplasia, strongly support the hypothesis that MMTV-
DN89b-catenin acinar tumors develop from expansion of alveolar
progenitors, or by skewing the lineage of a bipotent alveolar/
ductal progenitor towards an alveolar fate. This concept is
reminiscent of K14-DN80b-catenin effects on skin appendage fate
and consistent with our previous findings that known regulators of
alveolar progenitor determination, expansion and differentiation
influence the MMTV-DN89b-catenin-phenotype [18,38].
Many studies have assumed that MMTV-DN89b-catenin and
MMTV-Wnt1 exert a similar tumorigenic effect and have studied
these models interchangeably. Where phenotypic differences have
been noted Wnt1’s potential to activate non-canonical pathways
has been speculated upon but not experimentally addressed. Our
Figure 5. MMTV-DN89b-catenin and MMTV-Wnt1 tumors show expansion of distinct CD24/CD49f cell populations. CD24/CD49f
marker profile of (A) total, (B) EGFP- and (C) EGFP
hi cells from MMTV-DN89b-catenin tumors. Note the enrichment and upward shift of EGFP
hi cells
within the CD24
high/CD49f
low subpopulation. CD24/CD49f marker profile of (D) total, (E) EGFP- and (F) EGFP
hi cells from MMTV-Wnt1 tumors. Note
EGFP
hi cells are shifted rightward within the CD24
high/CD49f
low subpopulation and upward within the CD24
low/CD49f
high subpopulation. CD24/CD49f
marker profile of (G) total cells from a wt littermate. (H) EGFP
+ cells from MMTV-DN89b-catenin tumors show higher colony forming efficiency than
EGFP
(2) and total sorted cells. (I) Immunofluorescence analysis shows these EGFP
+ cells are generate colonies containing K14
+ and K8
+ cells.
doi:10.1371/journal.pone.0004537.g005
Wnt/Hh in Mammary Tumors
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models lies in the failure of Wnt1 to induce autocrine canonical
signaling and its ability instead to induce a robust paracrine
canonical response within a basally located K14
+ cell population.
Several pieces of data suggest that this Wnt1-responsive K14
+ cell
population consists of a stem cell or early bipotent progenitor
population. First, the EGFP
hi expressing cells within the
CD24
lowCD49
high subpopulation is skewed towards higher
CD49f expression, a feature associated with MRU capacity, and
depleted of cells with lower CD49f expression, a feature associated
Figure 6. Hh pathway activity within the MMVT-Wnt1 tumor microenvironment. Gli1-lacZ expression is restricted to lymphatic vessels
(arrow) in mammary whole mounts of (A) control Gli1
+/lz mice, and absent from tumor sections from (B) MMTV-DN89b-catenin;Gli1
+/lz mice, but is
strongly expressed in (C) MMTV-Wnt1;Gli1
+/lz tumor whole mounts. In sections of MMTV-Wnt1;Gli1
+/lz tumors (D) Gli1-lacZ expression is found within
stromal cells and occasional p63
+ cells (arrow). (E) Hyperplastic MMTV-Wnt1;Gli1
+/lz mammary whole mounts from 12 week-old mice show lack of
reporter expression within unstained mammary hyperplasia and restriction to lymphatics and melanocytic hyperplasia (boxed area).
doi:10.1371/journal.pone.0004537.g006
Wnt/Hh in Mammary Tumors
PLoS ONE | www.plosone.org 8 February 2009 | Volume 4 | Issue 2 | e4537with mature myoepithelial populations [27]. EGFP
hi responding
cells that segregate into the CD24
highCD49
low group are also
skewed rightwards and express K14, a profile recently ascribed to
a CD61
+ bipotent progenitor population shown to have cancer
stem cell properties [22,28]. Second, luminal and basal cell-types
from MMTV-Wnt1 tumors share common genetic changes
suggesting that the cell-type transformed by Wnt1 is a progenitor
of both lineages [19]. Third, Wnt1 produces ductal defects (see
fig 1) in addition to suppressing alveolar secretory differentiation
[39]. Collectively, these results suggest that MMTV-Wnt1 induces
expansion of a multipotent basal cell-type that precedes commit-
ment to the ductal/alveolar as well as luminal/basal lineages.
Wnt1 leads to Hh pathway activity in melanocytic
hyperplasia and their surrounding stroma
A further source of disparity between the MMTV-DN89b-
catenin and MMTV-Wnt1 phenotypes relates to the ability of the
latter to affect additional surrounding cell-types. Of note, stromal
hyperplasia (see Fig. 2L and 3E) is prominent within the early
hyperplastic glands and tumors of MMTV-Wnt1 mice but is
absent from glands and tumors of MMTV-DN89b-catenin mice.
Another striking example is the dramatic effect on melanocyte
populations. Our results show that massive melanotic deposits
within the mammary fatpad are a hallmark of pigmented MMTV-
Wnt1 mice and that large numbers of amelanotic melanocyte
precursors accumulate around the primary lactiferous ducts of
both pigmented and albino MMTV-Wnt1 animals. Murine
melanocyte precursors normally reside in the hair follicle bulge
and are not detected in the mammary fatpads of wt or MMTV-
DN89b-catenin mice. Although both canonical and non-canonical
Wnt signaling have been implicated in promoting melanocyte
proliferation, migration and differentiation at other body sites
[40], the lack of Conductin-lacZ reporter expression within the
mammary melanocytic hyperplasia strongly favors non-canonical
signaling. Intriguingly, our results show a tight correlation between
positive Hh signaling within a minor melanocytic subpopulation
and their surrounding stromal neighbors and the massive
accumulation of mobilized, differentiating melanocytes in
MMTV-Wnt1 glands. Current literature highlights a dualistic
role for Hh signaling in melanocyte biology [41,42]. Gli3R
repression of Hh signaling is essential for melanoblast specification
at certain body regions during development. However, consistent
with our suggestion that Hh pathway activity is linked to
melanocytic hyperplasia, one report has shown that positive Hh
Figure 7. Melanocytic hyperplasia associated with Hh pathway activity is a hallmark of all MMTV-Wnt1 mammary glands. Mammary
whole mount and sections from pigmented MMTV-Wnt1 mice show melanin deposition (A, B) and presence of melanocytes (C) detected by anti-
S100b (DAKO #Z0311). Whole mounts and sections from albino (D, G) and pigmented (E) MMTV-Wnt1;Gli1
lz/+ mice show Gli1-lacZ expression around
the primary ducts localizing with melanin (E). Conductin-lacZ expression (blue) does not colocalize with S100b
+ (brown) (F). However a minor subset
of S100b
+ melanocytes (brown) (red arrows) and many of their neighboring stromal cells express the Gli1-lacZ reporter (blue) (G).
doi:10.1371/journal.pone.0004537.g007
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metastasis [42]. Importantly, our observations show that Wnt and
Hh pathway activity are linked in the induction of these
melanocytic accumulations and suggest that these pathways may
contribute to pigmentary changes arising close to the nipple in
association with an underlying breast carcinoma.
Wnt1 leads to Hh pathway activity within the mammary
tumor microenvironment
A second major site of focal Hh pathway activity is found within
MMTV-Wnt1 tumors. Of note, Hh pathway activity was
restricted to the Wnt-1 tumor microenvironment and was not
observed within the Wnt-1 hyperplasia and thus correlated with
Wnt1 tumor onset. Hh pathway repression is essential for
embryonic mammary development and repression remains critical
to homeostasis in the postnatal gland [37]. Pathway activation
distorts mammary development, and is found in both epithelial
and stromal compartments of human breast cancers [37,43–46].
Intriguingly, Gli1-lacZ is expressed within a minor subset of p63
+
basal cells in Wnt1 tumors and Ihh has been proposed to regulate
proliferation of progenitors from stem cells via regulation of p63
isoform expression and to promote human mammosphere
formation, considered to be a surrogate in vitro assay of stem cell
proliferation [47,48]. However the most prominent site of Hh
pathway activity in MMTV-Wnt1 mice occurs in stromal cells
exclusively within the tumor microenvironment. Whether stromal
Hh pathway activation is essential for breast tumor onset remains
to be determined. However, the importance of this possibility has
been underscored by a recent study showing an essential role for
stromal Hh pathway activity in supporting tumor cell growth of
xenografted pancreatic and colonic human cancers and cell lines
[49]. Given that MMTV-Wnt1 tumors are enriched in cells with
stem/progenitor characteristics, we speculate that stromal Hh
pathway activity may be indicative of the step when CSCs co-opt
bystanders to become complicit in tumor formation by forming a
supportive CSC niche. Currently the relative importance of Hh
pathway activity within epithelial and stromal compartments of
tumors is a matter of heated debate [49,50]. As MMTV-Wnt1
tumors recapitulate the pattern of activity reported for human
breast tumors they may provide as a useful genetic model to dissect
the contribution of Hedgehog signaling within these different cell
types to tumor onset and progression.
In summary our data show that Wnt1 and DN89b-catenin
generate distinct tumors at least in part through activating
canonical signaling in distinct progenitors and through Wnt-
specific paracrine effects on multiple cell-types. Our data also show
that Wnt 1 expression is linked with focal Hedgehog pathway
activation in melanocytic nevi and mammary tumors. These data
suggest Hh pathway activity and pigmentary changes may have
utility as indicators of breast tumor onset induced by excess or
unopposed Wnt ligand.
Materials and Methods
Ethics Statement
Animal maintenance and experimental procedures were in
accordance with the NIH Guidelines for Animal Care and Use
and were approved by the Institutional Animal Care and Use
Committee of New York University Medical School.
Mice
MMTV-Wnt1 and MMTV-DN89b-catenin mice were as
described [13]. Axin2-d2EGFP, Conductin
+/lz, Gli1
+/lz, Ltpb1L
+/lz
were provided by Drs. Franke Costantini, Columbia University,
Alexandra Joyner, Sloan Kettering Institute and Velocigene,
Regeneron Pharmaceuticals, Inc. [32,33,36,51].
Mammary Whole Mount Staining
To detect lacZ expression, mammary glands and tumors were
fixed in 4% paraformaldehyde (PFA) in 16 phosphate buffered
saline (PBS) (PFA; Sigma Aldrich, St. Louis, MO) for 1 h, washed
thrice in rinse buffer (2 mM MgCl2, 0.1% sodium deoxycholate,
0.2% NP40 in PBS) for 1 h each and stained overnight at room
temperature in X-gal staining solution (50 mg/ml 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside in rinse buffer containing
5 mM potassium ferricyanide, 5 mM potassium ferrocyanide)
(Applichem, Cheshire, CT). After staining, glands and tumors were
rinsed in 16PBS, post-fixed in 4% PFA overnight and processed for
paraffin embedding. The tissues were sectioned, counterstained with
Nuclear Fast Red (Polyscientific, Bay Shore, NY) and mounted for
histological analyses. For whole mount analysis, X-gal stained
mammary glands were counterstained with carmine, cleared and
mounted as described http://mammary.nih.gov/tools/.
Histology
Tissues were either fixed in PFA and X-gal stained as described
above or fixed in 10% phosphate buffered formalin overnight,
then processed and embedded in paraffin. 4 m sections were
deparaffinized with xylene (or citrosolve for X-gal stained tissue)
and rehydrated through a graded series of ethanol. Citric acid
antigen retrieval was performed for all antibodies by microwaving
in 6.53 mM sodium citrate pH 6.0 for 30 min at 1.21 kilowatts.
Rabbit antibodies against K14 (cat# PRB155P, Covance,
Berkeley, CA) (1:2000), MUC1 (1:500) (Abcam), laminin (1:100)
(Sigma), S-100b (1:4000)(Dako #Z0311), mouse antibodies
against K18 (cat# 61028, Progen Biotechnik, Heidelberg,
Germany), estrogen receptor (1:500) (DAKO, Carpinteria, CA),
and guinea-pig anti-vimentin (1:1000)(Progen) were detected using
biotin labeled secondary antibodies (Vector Labs, Burlingame,
CA) (1:1000) in conjunction with streptavidin peroxidase (Fisher
Scientific, Suwanne, GA) that was colorimetrically detected using
diaminobenzidine (cat# K3466, DakoCytomation, Carpinteria,
CA). For S-100b staining, sections were subjected to antigen
retrieval with 0.1% trypsin (Sigma #T0303), 0.1% CaCl2 in
50 mM Tris-HCl, pH 7.6 at 37uC for 45 min in a humidified
chamber. Slides were washed continuously under running tap
water for 5 min and processed for immunohistochemistry. Azure
B staining was performed as described [52].
Mammary Epithelial Cell Isolation and Flow Cytometry
Mammary glands and tumors were minced and digested for 6–
7 h at 37uC in EpiCult-B Medium supplemented with 5% fetal
bovine serum (FBS) containing 300 U ml
21 collagenase and
100 U ml
21 hyaluronidase. Digests were pipetted 8–12 times
and vortexed for 5 seconds every hour. After dissociation, cells
were pelleted at 3506g for 5 min and resuspended in a 1:4
mixture of Hanks’ Balanced Salt Solution containing 2% FBS (HF)
and ammonium chloride and centrifuged again. Cell pellets were
gently dissociated for 3 min in 5 ml of pre-warmed 0.25% trypsin-
EDTA. 10 ml of cold HF was added. Cells were pelleted by
centrifugation and resuspended for 1 min in 5 mg ml
21 of pre-
warmed dispase II containing 0.1 mg ml
21 DNase I, then diluted
with 10 ml of cold HF and filtered through a 40-mm mesh. All
reagents were from StemCell Technologies Inc. [27]. All
antibodies were purchased from BD Pharmingen unless otherwise
noted. Cells at a concentration of 2.5610
6 per 100 mlo f2 %
bovine serum albumin (BSA) were incubated on ice for 30 min
with primary antibodies: 0.5 ng/ml of biotinylated TER119 (cat#
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ythrin (PE) (cat# 553262), and 0.25 ng/ml of CD49f-allophyco-
cyanin (APC) (cat# FAB13501A, Minneapolis, MN, R&D
Systems). Cells were washed once in 200 ml 2% BSA, stained
with 1.5 ng/ml of streptavidin-Alexa488 on ice for 30 min,
washed again and resuspended in 2% BSA. 1 mg/ml of 7-
aminoactinomycin D (7-AAD) (cat# 00-6993-50, San Diego, CA,
eBioscience) was added just prior to data acquisition. Flow
cytometric data was acquired on a FACS Caliber cytometer at
the NYU Skirball FACS Core Facility and analyzed using FlowJo
software [27]
Colony-Forming Assays
NIH-3T3 cells were irradiated in suspension at 20Gy and
seeded as a feeder layer 24 h prior to assay, at a concentration of
1.9610
4 cells/well in 24-well plates (Corning Incorporated,
Corning, NY). Lineage
+ cells were depleted prior to sorting using
the EasySep Cell Biotin Selection Kit (StemCell Technologies Inc.)
using TER119, CD31, and CD45 and CD140A (eBioscience)
antibodies. GFP
+, GFP
2 and Total Sorted tumor cells were sorted
into 1 ml of 100% FBS using a MoFlo cell sorter, excluding cell
debris, cell doublets, and autofluorescent cells. Sorted cell
populations were centrifuged at 350 g for 3 mins, resuspended
in a 300 ml, assessed for viability in 50% Trypan Blue and plated
at limiting dilution. Media (EpiCultB+bullet, 5% FBS, 100 U/ml
Penicillin/Streptomycin, 1 mg/ml Ciprofloxacin, 0.25 mg/ml
Fungizone) was changed 48 h later to medium lacking FBS.
Colonies were fixed after 6 days in 50:50 acetone:methanol at
220uC for 3 min and counted. Cells were stained with primary
antibodies to K8 (Progen Cat#65138) and K14 (1:2,000, Covance
PRB-155P) for 30 min, washed three times in PBS, stained with
goat anti-mouse (1:100, Invitrogen Cat#A11801) and donkey
anti-rabbit (1:100, Chemicon Cat#AP182C) followed by three
washes in PBS.
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